Team

Anne Galy is an expert in the field of cell and gene therapies. She created and directs the Inserm Technology Research Accelerator in Genomic Therapy (www.art-tg.com), which is part of the Inserm network of integrators in biotherapy and bioproduction. Her current work focuses on developing new gene immunotherapies, particularly for infectious diseases, developing new technologies, and accelerating the transfer of innovative gene therapies to human clinical trials. Her work contributes to several European and national networks in the field of innovative therapies. Anne Galy is the author of over 130 publications (ORCID:0000-0002-0153-4392), she is a member of the board of directors of the European Society for Gene Therapy, and her work has been recognized with several awards, including the Grand Prize of the French National Academy of Pharmacy in 2023.